P3 Health Partners (PIII) Cash from Financing Activities (2021 - 2025)

P3 Health Partners (PIII) has 5 years of Cash from Financing Activities data on file, last reported at $12.9 million in Q4 2025.

• Quarterly Cash from Financing Activities fell 61.82% year-over-year to $12.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72.8 million (down 26.28% YoY) and the FY2025 annual result came in at $72.8 million, down 26.28% from the prior year.
• Cash from Financing Activities slipped to $12.9 million in Q4 2025, from $14.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $87.2 million in Q2 2023 to a low of -$2.5 million in Q3 2024.
• A 5-year average of $15.6 million and a median of $12.5 million in 2021 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 5331.07% — and 2023, when it soared 7134.38%.
• Tracing PIII's Cash from Financing Activities over 5 years: stood at -$22587.0 in 2021, then surged by 66509.88% to $15.0 million in 2022, then slumped by 105.6% to -$840000.0 in 2023, then surged by 4113.93% to $33.7 million in 2024, then tumbled by 61.82% to $12.9 million in 2025.
• The last three Cash from Financing Activities figures came in at $12.9 million (Q4 2025), $14.7 million (Q3 2025), and $14.6 million (Q2 2025), per Business Quant data.